Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells
- 1 May 1998
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 85 (1) , 87-95
- https://doi.org/10.1016/s0165-5728(98)00020-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Ins and outs of LFA-1Immunology Today, 1995
- Structure and function of adhesion receptors in leukocyte traffickingImmunology Today, 1995
- Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.The Journal of Experimental Medicine, 1993
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.The Journal of Experimental Medicine, 1990
- Experimental autoimmune encephalomyelitis in “low” and “high” interleukin 2 producer ratsCellular Immunology, 1989
- Long‐term depletion of cd8+ t cells in vivo in the rat: no observed role for cd8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitisEuropean Journal of Immunology, 1988
- Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.The Journal of Experimental Medicine, 1987
- Enhanced proliferation, survival, and yield of cultured myelin basic protein (MBP)-reactive Lewis rat lymph node cells following dual activation with concanavalin A and MBPCellular Immunology, 1981
- Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: Comparison of in vitro activation by concanavalin A and myelin basic proteinCellular Immunology, 1980